GC Biopharma Executive and Leadership Team

Jin Pyun, the Chief Executive Officer, Gc Ventures, A Subsidiary of Gc Holdings (US) at GC Biopharma, architects the strategic direction and operational execution for the company's venture capital arm. Pyun identifies and invests in promising biotechnological innovations, fostering synergistic growth opportunities that align with GC Biopharma's core objectives. This leadership position involves rigorous due diligence, portfolio management, and driving value creation within emerging life science companies. Jin Pyun's oversight ensures that Gc Ventures actively contributes to the parent company's long-term vision by exploring novel technologies and therapeutic modalities. The Chief Executive Officer's role is pivotal in expanding GC Biopharma's influence and capabilities through strategic financial backing and technological integration, thereby accelerating the development of next-generation biopharmaceutical solutions and securing a competitive edge in the global market.

Seongyeol Kim, the Chief Financial Officer at GC Biopharma, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, Kim ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, optimizing investment strategies, and securing funding to support GC Biopharma's research and development initiatives. By meticulously analyzing market trends and economic indicators, Seongyeol Kim drives financial performance and supports sustainable growth. Kim's oversight extends to risk management, ensuring the company's financial resilience in a dynamic global market. The Chief Financial Officer's strategic guidance is crucial for maintaining investor confidence and facilitating the company's expansion into new therapeutic areas and international markets, directly impacting the company's ability to deliver life-saving biopharmaceutical products.

Francis Kim, the President at GC Biopharma, drives overarching corporate strategy and operational excellence across key business units. Kim's leadership ensures seamless integration of research, development, manufacturing, and commercialization efforts, aligning all functions with the company's mission to advance global health. This executive role involves fostering a culture of innovation and accountability, empowering teams to achieve ambitious targets in vaccine and plasma-derived therapy development. Francis Kim's strategic oversight is critical for navigating the complex regulatory landscapes and market dynamics inherent in the biopharmaceutical industry. By championing cross-functional collaboration, Kim enhances efficiency and accelerates the delivery of life-saving treatments to patients worldwide, reinforcing GC Biopharma's commitment to scientific advancement and patient well-being.

Eun Huh, the President at GC Biopharma, directs critical operational functions and strategic initiatives focused on enhancing manufacturing capabilities and global supply chain efficiency. Huh's leadership ensures the consistent production of high-quality vaccines and plasma-derived therapies, meeting stringent international standards. This executive role involves optimizing production processes, managing resource allocation, and driving technological advancements within manufacturing facilities. Eun Huh's strategic focus on operational excellence supports GC Biopharma's capacity to scale its offerings and respond effectively to global health demands. By overseeing the intricate logistics of production and distribution, Huh plays a vital part in ensuring that essential biopharmaceutical products reach patients reliably, underscoring the company's dedication to accessibility and impact.

Kwangsu Lee, the Global Chief Marketing Officer, Business Development Head of & External Manufacturing at GC Biopharma, spearheads global market penetration and strategic business expansion. Overseeing all marketing initiatives, Lee drives brand visibility and product adoption across diverse international territories. Simultaneously, Kwangsu Lee directs business development efforts, identifying and cultivating new partnership opportunities and market segments to fuel company growth. This dual focus extends to managing external manufacturing relationships, ensuring efficient and high-quality production capabilities align with global demand. Lee's strategic vision integrates market intelligence with operational execution, positioning GC Biopharma's innovative therapies for maximum impact. The comprehensive scope of this role ensures seamless coordination between market outreach, strategic alliances, and manufacturing capacity, critical for delivering on the company's mission.